Ozempic-maker sues rival, accusing it of false advertising
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising.
Novo Nordisk, the maker of Wegovy and Ozempic, has launched legal action accusing its arch rival Eli Lilly of false advertising. This story matters for General News readers tracking general. Reported by bbc.co.uk. Read the full original at the source link below.
Originally reported by bbc.co.uk. NewsDebate curates and briefs the general news stories that matter. Our editorial policy →